Research programme: calcium channel antagonists - AjinomotoAlternative Names: AGS 1164; APJ 2708; APJ 2929
Latest Information Update: 11 Oct 2010
At a glance
- Originator Ajinomoto
- Class Dihydropyridines
- Mechanism of Action Calcium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Neuropathic pain